What Kyocera Medical Technologies does

Kyocera Medical Technologies, Inc. (KMTI) is a U.S. orthopedic and spinal implant manufacturer and a wholly-owned subsidiary of Kyocera Corporation (Japan), operating through Kyocera International, Inc. The company was established in March 2019 when Kyocera acquired the major assets of Renovis Surgical Technologies, Inc. (founded 2009) and transferred them into a new California-based entity with headquarters in Redlands and an R&D center in Austin, Texas. KMTI manufactures and markets spine interbody fusion systems (Tesera family), hip and knee reconstruction systems (A450/A400 hip, A200 knee), trauma fixation products (T700 cannulated screws), and biosynthetic bone scaffolds (ReBOSSIS/BioCera).

The company's product portfolio is differentiated by proprietary materials and additive manufacturing: Tesera Trabecular Technology is a patent-pending 3D-printed porous titanium structure engineered for bone ingrowth, first cleared by FDA in 2013 for a stand-alone ALIF cage and extended across cervical, posterior lumbar, and lateral interbody applications; E-MAX is a trademarked highly crosslinked polyethylene blended with vitamin E for ultra-low wear and oxidation resistance, developed in partnership with Massachusetts General Hospital and Cambridge Polymer Group; Resilience is a low-modulus 3D-printed titanium design with dual-wall lattice architecture at approximately 68% porosity; DUO-Texture provides micro and macro surface texturing for bone on-growth; and BioCera/ReBOSSIS is positioned as a unique electrospun microfiber biosynthetic scaffold composed of β-TCP, CaCO3, silicon, and PLGA. Multiple of these products have achieved first-mover FDA 510(k) clearances, including the first 3D-printed titanium stand-alone cervical cage (2016).

KMTI operates a hybrid go-to-market combining U.S. distributor relationships (with a public distributor inquiry channel) and direct field sales targeting orthopedic spine surgeons, joint reconstruction surgeons, and trauma surgeons across hospitals and ambulatory surgical centers in North America. Revenue is generated through one-time device sales with quote-based pricing; pricing is not publicly disclosed. The company is privately held with no third-party institutional investment disclosed, benefiting from Kyocera Corporation's balance sheet and global R&D resources while operating at a sub-50-employee scale focused on the U.S. market.

Name

Kyocera Medical Technologies

Legal name

KYOCERA Medical Technologies, Inc.

Website

https://kyocera-medical.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Kyocera Medical Technologies is a U.S. orthopedic and spinal implant manufacturer (Redlands, CA; R&D in Austin, TX) and wholly-owned Kyocera Corporation subsidiary, producing Tesera 3D-printed porous titanium spine devices, hip/knee reconstruction systems, trauma fixation, and BioCera/ReBOSSIS biosynthetic bone scaffolds for U.S. hospitals and surgical centers via distributors and direct sales.

Ownership category

akta.pro rank

Product category

Orthopedic Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Spine Implants & Motion Preservation (Fusion/Disc/Interspinous) (HLAHAEAC)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

Keywords

• Orthopedic implants
• Spinal fusion devices
• Joint reconstruction
• Trabecular titanium
• Biosynthetic bone scaffolds

Headquarters

HQ city

Redlands

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

1. Orthopedic Implants Sales: Kyocera Medical Technologies generates revenue through the sale of orthopedic implants and spinal devices, including hip systems, knee systems, spine fusion systems, trauma products, and biologics. The company sells primarily through distributor networks targeting hospitals and surgical centers in the US market.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Kyocera Medical Technologies designs, develops, and manufactures orthopedic and spinal implants, including interbody fusion cages, hip and knee arthroplasty systems, trauma fixation devices, and bone graft substitutes. The company leverages proprietary 3D-printed porous titanium (Trabecular Technology) and advanced polyethylene formulations (E-MAX) to deliver implants used by spine surgeons, orthopedic surgeons, and trauma surgeons in hospitals and surgical centers.

Differentiator

Problem solved

Functional benefit

Brands

• ReBOSSIS: Biosynthetic bone scaffold with electrospun microfiber construction, composed of β-TCP, CaCO3, silicon, and PLGA. The only biosynthetic scaffold with electrospun microfiber construction featuring excellent handleability and hydrophilic properties.
• BioCera Fibers
• Tesera
• E-MAX

Quantifiable outcome

• E-MAX polyethylene achieves ultra-low wear and antioxidant protection against oxidation in vivo

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Renovis Surgical Technologies, Inc.acquiredStrategic or Co-development PartnerIn January 2019, Kyocera Corporation's U.S. headquarters (Kyocera International, Inc.) acquired major assets of Renovis Surgical Technologies relating to artificial joint and spinal products. The assets were transferred into a new company named Kyocera Medical Technologies, Inc. Renovis, founded in 2009, was a market leader in 3D-printed implants with Tesera Trabecular Technology and advanced bearing surface technology.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• SeaSpine: Pure-play spine and orthobiologics company (now combined with SI-BONE). Closely comparable to KMTI in scale and product focus, with both 3D-printed interbody cages (NanoMetalene, Wave) and a bone graft substitute line.
• Globus Medical: Pure-play spine and orthopedic implant company (combined with NuVasive). Closest direct peer to KMTI's spine franchise, also offering 3D-printed titanium interbody cages (HEDRON, COALITION, Anthem) and an expanding joint reconstruction line.
• Orthofix Medical: Smaller U.S.-listed orthopedic and spine company focused on spine fusion, biologics (FiberFuse, Virtuos) and orthopedic solutions. Closely comparable in size, product mix (spine + biologics), and channel approach to KMTI.
• Alphatec Holdings: U.S.-focused, surgeon-centric spine company with a portfolio of interbody cages, fixation systems and biologics. Direct competitor to KMTI's spine franchise and similarly reliant on a mix of direct sales and distributors.

Broad incumbents

• Medtronic: Global spine market leader (via the legacy Medtronic Spinal & Biologics business, now operating under the name 'Yujeong'). A broad incumbent competitor in spine fusion, cervical, interbody and biologics, overlapping heavily with KMTI's spine portfolio.
• Zimmer Biomet: Top-tier orthopedic implant manufacturer in hip and knee reconstruction. KMTI's A450, A400, and A200 systems compete directly in the same joint reconstruction categories Zimmer Biomet dominates.
• Stryker: One of the largest orthopedic and spine implant companies in the world. Directly comparable to Kyocera Medical Technologies across joint reconstruction (hip, knee) and spine, with its own 3D-printed Tritanium platform that competes head-to-head with Tesera.
• B. Braun / Aesculap: Diversified medical device company with Aesculap orthopedic and spine implants (including 3D-printed PlasmageiT titanium cages). Competes with KMTI in hip, knee, spine and biologics across the U.S. market.
• Smith+Nephew: Broad orthopedic and sports medicine player with hip, knee, and trauma reconstruction products. Comparable to KMTI as a diversified orthopedic device incumbent competing for the same hospital and surgeon accounts.
• Integra LifeSciences: Specialty surgical and orthopedic company with a spine & orthopedic portfolio (including orthobiologics). Comparable as a mid-sized diversified orthopedic/specialty implant company serving U.S. hospitals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@kyoceramedicaltechnologies5683
• LinkedInlinkedin.com/company/kyocera-medical-technologies
• Instagraminstagram.com/kyoceraspine

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kyocera Medical Technologies